Patient Guide: A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 144 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04640623
Status: ACTIVE_NOT_RECRUITING
Condition: Urinary Bladder Neoplasms
Phase: PHASE2

Find a Study Location Near You

This study is available at 144 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • Los Angeles, California
  • Sherman Oaks, California
  • • And 141 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily